Forma-I is a non-invasive procedure designed to address dry eye syndrome by stimulating the meibomian glands, which are responsible for producing the oily layer of tears. This treatment utilizes radiofrequency technology to improve gland function, alleviate dry eye symptoms, and enhance eye comfort and moisture.


Developed by InMode, a leader in medical technology, Forma-I is a non-surgical procedure that uses radiofrequency technology to address dry eye syndrome by improving meibomian gland function, ultimately enhancing tear production and relieving dry eye symptoms. This helps to heal and restore normal oil flow which also helps smooth fine lines and wrinkles around the eyes.
Individuals experiencing dry eye symptoms, particularly due to meibomian gland dysfunction, are potential candidates for this treatment. It is essential to consult with a healthcare professional to determine candidacy.
Forma-I is specifically designed to address the meibomian glands located in the eyelids.
Preparation:
The patient’s eyes are typically numbed with anesthetic eye drops to ensure their comfort during the procedure. The specialist may also clean the eyelids and lashes to remove any debris or makeup.
Meibomian Gland Expression:
The specialist uses a device or specialized instrument to apply controlled radiofrequency energy to the meibomian glands located within the eyelids. This energy gently warms and expresses the glands, helping to release the thickened and obstructed meibum (lipid) that contributes to dry eyes.
Tear Film Improvement:
The combination of heat and meibomian gland expression improves the quality of the tear film by enhancing the lipid layer, which helps to prevent excessive evaporation of tears.
Treatment Duration:
The Forma-I dry eye treatment usually takes a relatively short amount of time, with the procedure lasting around 15 to 30 minutes for both eyes.
Post-Treatment Care:
After the treatment, patients may experience mild redness or temporary sensitivity to light. The specialist provides post-treatment instructions, which may include recommendations for artificial tears, lid hygiene, and lifestyle modifications to manage dry eye symptoms.
Follow-Up Appointments:
Patients may need to schedule follow-up appointments to assess their progress and determine if additional treatments or ongoing management are necessary.
The duration of a Forma-I session typically varies depending on the extent of the treatment. However, the procedure generally takes around 15 to 30 minutes.
Forma-I is non-invasive, and most patients experience minimal to no downtime. Patients can typically resume their daily activities immediately following the procedure.
Results may vary among individuals, but some improvement in dry eye symptoms is often noticeable within a few weeks of the treatment. Full benefits typically become more apparent with continued gland function enhancement.
The longevity of Forma-I results can vary. For some patients, the effects can be long-lasting, while others may require periodic maintenance treatments to sustain gland function and alleviate dry eye symptoms.
The cost of Forma-I can vary depending on the clinic, the extent of the procedure, and the number of sessions required. On average, a single session may range from $300 to $700.
Forma-I is generally considered safe, but there may be mild side effects, including temporary redness or swelling. Consultation with a healthcare professional is essential to assess potential risks and benefits.

